发明授权
US08673581B2 sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases
有权
sCD40L和胎盘生长因子（PLGF）作为心血管疾病的生物化学标记物组合
- 专利标题： sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases
- 专利标题（中）： sCD40L和胎盘生长因子（PLGF）作为心血管疾病的生物化学标记物组合
-
申请号： US13613010申请日： 2012-09-13
-
公开(公告)号： US08673581B2公开(公告)日： 2014-03-18
- 发明人: Andreas M. Zeiher , Christopher Heeschen , Stefanie Dimmeler , Christian Hamm
- 申请人： Andreas M. Zeiher , Christopher Heeschen , Stefanie Dimmeler , Christian Hamm
- 申请人地址： DE Marburg
- 专利权人： Siemens Healthcare Diagnostics Products GmbH
- 当前专利权人： Siemens Healthcare Diagnostics Products GmbH
- 当前专利权人地址： DE Marburg
- 代理机构： Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- 优先权： DE10253525 20021116; DE10316059 20030408
- 主分类号： G01N31/00
- IPC分类号： G01N31/00 ; G01N33/53
摘要：
The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.
公开/授权文献
信息查询
